Adult And Pediatric Hemoconcentrators Market size is slated to witness a major upsurge from 2022 to 2028. This is due to the increasing reliance of perfusionists and surgeons on hemoconcentrators products during cardiopulmonary surgery to maintain higher hematocrit levels and reduce the requirement of additional blood products. Furthermore, the rising burden of heart diseases worldwide will further augment industry growth over the estimated timeline, given the significant usage of cardiopulmonary bypass in heart surgery. Hemoconcentrators refer to fluid removal devices deployed in cardio bypass surgery. This device is inserted in the extracorpeal circuit to control hemodilution, reduce the use of more blood products, and maintain hematocrit levels. Known as a great asset in fluid management, it lowers instances of edema, protein concentration, and organ dysfunction.
Strong focus on cardiac care and the escalating incidence of cardiovascular diseases in low-income countries will foster the adult and pediatric hemoconcentrators market trends over 2022-2028. As per the National Health Authority’s data, private hospitals account for over 70% of utilization of cardiac care, which could proliferate the use of hemoconcentrator in extracorporeal blood circuits to manage fluids in cardiac patients. Likewise, the growing prevalence of congenital heart diseases among children, alongside the escalating elderly population, will further contribute to hemoconcentrator uses over the forthcoming years.
Considering type, the adult hemoconcentrators segment will hold a considerable share in the adult and pediatric hemoconcentrators industry by 2028. Growth from the segment is on account of the increasing cases of obesity among older adults in rural areas, as overweight is linked to hypertension and an enlarged left ventricle, thus increasing the risk of heart failure. With regards to end-use, the ambulatory surgical center segment is set to exhibit a strong growth rate through the forecast spell. This is driven by the myriad benefits of surgery conducted at the ASCs, including reduced surgical site infections and superior surgical treatment.
Regionally, the Asia Pacific adult and pediatric hemoconcentrators market is likely to register commendable revenue by 2028. This can be credited to the rising per capita income, surging healthcare expenditure, and the increased prevalence of CVDs in the region. As per the Global Burden of Disease’s data, nearly 24.8% of all deaths is due to CVDs in India. Situations such as these, along with the notable improvements in treatment related to coronary artery bypass grafting procedures, will also boost the adoption of hemoconcentrator devices over the projected timeframe.
Prominent players functioning in the adult and pediatric hemoconcentrators industry include Medtronic, Terumo Cardiovascular Systems, MAQUET (Getinge), Andocor, Medivators (Cantel Medical Corporation), Nipro, and Sorin, among others. These firms are implementing varied strategies such as new product launches, mergers, and acquisitions to boost their presence across the competitive market.
In light of the coronavirus outbreak, a sharp decline in the rate of heart surgeries and a rise in death cases of heart surgery patients were observed during the pandemic in the United States. Patients diagnosed with acute coronary syndromes, especially those who need coronary artery bypass graft surgery, are at higher severity risks of COVID-19. While extracorporeal circulation results in the activation of microcirculatory and endothelium networks, the virus may also course with severe inflammation, plaque rupture, and other severe conditions, thereby limiting surgical interventions. This significant reduction in heart surgeries amid the crises has created a hindrance to the steady growth of the adult and pediatric hemoconcentrators industry in recent months. However, the rising awareness about the negative effects of the virus in organs like the lungs and heart may aid industry recovery in the near future.
Market, By Type
Market, By End-use
The above information is provided for the following regions and countries: